ScholarIQanswers from OpenAlex & ORCID
Taofeek K. Owonikoko
ResearcherPublications, citations & collaboration network
Taofeek K. Owonikoko is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Taofeek K. Owonikoko have?
ScholarIQindexed works
Taofeek K. Owonikoko has 705 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Taofeek K. Owonikoko have?
ScholarIQcitation count
Taofeek K. Owonikoko has 58,750 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Taofeek K. Owonikoko?
ScholarIQh-index
Taofeek K. Owonikoko has an h-index of 88 in OpenAlex.
What is the i10-index of Taofeek K. Owonikoko?
ScholarIQi10-index
Taofeek K. Owonikoko has an i10-index of 259 in OpenAlex.
What is the ORCID of Taofeek K. Owonikoko?
ScholarIQorcid
The ORCID for Taofeek K. Owonikoko is on the source record.
What is the OpenAlex record for Taofeek K. Owonikoko?
ScholarIQopenalex
The OpenAlex for Taofeek K. Owonikoko is on the source record.
What are the most-cited papers on Taofeek K. Owonikoko?
ScholarIQmost cited works
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
Lori J. Wirth, Eric J. Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen H. Lorch, Francis P. Worden, Marcia S. Brose, Jyoti D. Patel, Sophie Leboulleux, Yann Godbert, Fabrice Barlési, John C. Morris, Taofeek K. Owonikoko, Daniel S.W. Tan, Oliver Gautschi, Jared Weiss, Christelle de la Fouchardière, Mark E. Burkard, Janessa Laskin, Matthew H. Taylor, Matthias Kroiß, Jacques Médioni, Jonathan W. Goldman, Todd M. Bauer, Benjamin Levy, Viola W. Zhu, Nehal J. Lakhani, Víctor Moreno, Kevin Ebata, Michele Nguyen, Dana Heirich, Edward Y. Zhu, Xin Huang, Luxi Yang, Jennifer Kherani, S. Michael Rothenberg, Alexander Drilon, Vivek Subbiah, Manisha H. Shah, Maria E. Cabanillas
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
Myung‐Ju Ahn, Byoung Chul Cho, Enriqueta Felip, Ippokratis Korantzis, Kadoaki Ohashi, Margarita Majem, Óscar Juan, Sabin Handzhiev, Hiroki Izumi, Jong Seok Lee, Rafał Dziadziuszko, Jürgen Wolf, Fiona Blackhall, Martin Reck, Jean Bustamante Alvarez, Horst-Dieter Hummel, Anne‐Marie C. Dingemans, Jacob Sands, Hiroaki Akamatsu, Taofeek K. Owonikoko, Suresh S. Ramalingam, Hossein Borghaei, Melissa L. Johnson, Shuang Huang, Sujoy Mukherjee, Mukul Minocha, Tony Jiang, Pablo Martínez, Erik S. Anderson, Luis Paz‐Ares
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
M. Catherine Pietanza, Saiama N. Waqar, Lee M. Krug, Afshin Dowlati, Christine L. Hann, Alberto Chiappori, Taofeek K. Owonikoko, Kaitlin M. Woo, Robert J. Cardnell, Junya Fujimoto, Lihong Long, Lixia Diao, Jing Wang, Yevgeniva Bensman, Brenda Hurtado, Patricia M. de Groot, Erik P. Sulman, Ignacio I. Wistuba, Alice P. Chen, Martin Fleisher, John V. Heymach, Mark G. Kris, Charles M. Rudin, Lauren A. Byers